Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy

Area of Science:

• Pediatric Neurology
• Epileptology
• Clinical Pharmacology

Background:

• Epileptic encephalopathy presents significant challenges in pediatric neurological care.
• Current treatment options for epileptic encephalopathy often have limitations.
• Identifying effective therapeutic strategies is crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of intravenous methylprednisolone therapy in children with epileptic encephalopathy.
• To assess changes in seizure frequency, electroencephalographic patterns, and neuropsychological status post-treatment.
• To determine the safety and long-term effects of this therapeutic regimen.

Main Methods:

• Retrospective study design involving eleven children diagnosed with epileptic encephalopathy.
• Administration of intravenous methylprednisolone (15-30 mg/kg/day for three days monthly, for four months) alongside existing antiepileptic drugs.
• Evaluation of seizure frequency, EEG findings (specifically generalized slow spike-and-wave discharges), and neuropsychological status before and after treatment.

Main Results:

• Statistically significant reductions in generalized slow spike-and-wave discharges (p<0.0028) and seizure frequency (p<0.013) were observed.
• These improvements were sustained even after the cessation of methylprednisolone pulse therapy.
• A globally positive outcome was achieved in 9 out of 11 patients (81.8%), with no significant persistent adverse effects.

Conclusions:

• Intravenous methylprednisolone pulse therapy is an effective treatment for reducing seizure frequency and improving EEG patterns in pediatric epileptic encephalopathy.
• The positive effects appear to be durable, persisting after treatment completion.
• Children with epileptic encephalopathy lacking underlying structural lesions may represent ideal candidates for this therapeutic approach.